2023
DOI: 10.1016/j.jneumeth.2022.109745
|View full text |Cite
|
Sign up to set email alerts
|

A review on Alzheimer’s disease classification from normal controls and mild cognitive impairment using structural MR images

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(3 citation statements)
references
References 224 publications
0
3
0
Order By: Relevance
“…AD is currently defined as dementia associated with Alzheimer‐type neuropathological change. However, the identification of ADNC in cognitively intact individuals implies pre‐clinical disease, the importance of which has been elevated by the ability to detect ADNC in‐life through imaging 124,125 and CSF biomarkers, 126 and by the therapeutic drive to treat early despite the only study with reduction in cognitive decline observed with medication was at a level that had a priori been deemed as not clinically significant 127,128 . Indeed, a biological definition of AD for research purposes, the ATN system based on Aβ, tau and neurodegenerative biomarkers, has been proposed by the National Institute on Ageing and Alzheimer's Association (NIA‐AA), which defines AD by the presence of pathological markers, 129 and which has provoked debate into its use in practice 130 .…”
Section: Significance Of High Pathology Prevalence and Lack Of Thresh...mentioning
confidence: 99%
“…AD is currently defined as dementia associated with Alzheimer‐type neuropathological change. However, the identification of ADNC in cognitively intact individuals implies pre‐clinical disease, the importance of which has been elevated by the ability to detect ADNC in‐life through imaging 124,125 and CSF biomarkers, 126 and by the therapeutic drive to treat early despite the only study with reduction in cognitive decline observed with medication was at a level that had a priori been deemed as not clinically significant 127,128 . Indeed, a biological definition of AD for research purposes, the ATN system based on Aβ, tau and neurodegenerative biomarkers, has been proposed by the National Institute on Ageing and Alzheimer's Association (NIA‐AA), which defines AD by the presence of pathological markers, 129 and which has provoked debate into its use in practice 130 .…”
Section: Significance Of High Pathology Prevalence and Lack Of Thresh...mentioning
confidence: 99%
“…While concussion history appears to be related to these measures of brain structure and function, it is currently unclear whether concussion history results in morphologic changes in gray matter. Gray matter morphologic measures change throughout development (20,21) and in neurodegenerative disorders like chronic traumatic encephalopathy (22), Alzheimer's disease (23) and Parkinson's disease (24). If cortical morphology is influenced by neurodegenerative disorders, the possible link between concussion history and these types of disorders later in life (25) may indicate that concussion history results in morphological changes in the brain and could serve as an objective, quantitative marker for cumulative concussion history.…”
Section: Introductionmentioning
confidence: 99%
“…These findings may help identify older individuals at risk of progressive cognitive impairment, thereby facilitating timely intervention. At present, a combination of structural MRI and machine learning is used to classify older individuals with cognitive impairment [ 16 , 17 ]. However, there are few models to identify quantitative regional FC biomarkers sensitive to cognitive scores among healthy older individuals.…”
Section: Introductionmentioning
confidence: 99%